A Feasibility Study of Mindfulness Training Transcranial Direct Current Stimulation (tDCS) in Adults With Overweight and Obesity
MINDED
1 other identifier
interventional
52
1 country
1
Brief Summary
This study will investigate the feasibility of combining an app-based Mindfulness training (MT) with at-home administered transcranial direct current stimulation (tDCS) in adults with overweight or obesity and assess whether MT with tDCS may improve weight-related behaviours in this population. Specifically, the study will assess whether MT+ active tDCS, as opposed to MT+ sham tDCS or waiting list control, reduces high calorie food craving and consumption. Findings will inform the development of a future large-scale randomised controlled trial. The trial will be conducted in the UK.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2023
CompletedFirst Posted
Study publicly available on registry
May 19, 2023
CompletedStudy Start
First participant enrolled
October 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 19, 2025
CompletedJuly 28, 2025
April 1, 2023
1.3 years
April 11, 2023
July 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
The feasibility of combining an app-based Mindfulness training (MT) with at-home Administered transcranial direct current stimulation (tDCS) by assessing intervention adherence
By assessing the tDCS session completed and the number of the MT sessions completed will be tracked through the app across the full 8 weeks
post treatment assessment (assessed at week 3 post start of treatment)
The feasibility of combining an app-based Mindfulness training (MT) with at-home Administered transcranial direct current stimulation (tDCS) by assessing intervention recruitment rate
Recruitment rate/month over months will be assessed to demonstrate that recruitment targets for the main trial can be met within an adequate time-frame.
post treatment assessment (assessed at week 3 post start of treatment)
The feasibility of combining an app-based Mindfulness training (MT) with at-home Administered transcranial direct current stimulation (tDCS) by assessing intervention retention rates
determine retention rates from randomization through intervention completion
post treatment assessment (assessed at week 3 post start of treatment) and at follow up (assessed at week 8 post start of treatment)
Participant views about treatment acceptability
Treatment Acceptability Questionnaire: asking participants to indicate if MT with self-administered tDCS is an acceptable approach to treatment and whether they would recommend MT + tDCS to a friend if they were struggling with their weight.
post treatment assessment (assessed at week 3 post start of treatment)
Secondary Outcomes (15)
Change in high calorie food intake in the lab
Baseline assessment, post treatment assessment (assessed at week 3 post start of treatment) and at follow up up (assessed at week 8 post start of treatment)
Change in food cravings
Baseline assessment, post treatment assessment (assessed at week 3 post start of treatment) and at follow up up (assessed at week 8 post start of treatment)
Change in weight loss using the bioelectrical impedance machine
Baseline assessment, post treatment assessment (assessed at week 3 post start of treatment) and at follow up up (assessed at week 8 post start of treatment)
Change in emotion regulation using Emotion Regulation Questionnaire
Baseline assessment, post treatment assessment (assessed at week 3 post start of treatment) and at follow up up (assessed at week 8 post start of treatment)
Change in mood using the The Depression, Anxiety and Stress-Scale
Baseline assessment, post treatment assessment (assessed at week 3 post start of treatment) and at follow up up (assessed at week 8 post start of treatment)
- +10 more secondary outcomes
Study Arms (3)
[Mindfulness training + real tDCS]
EXPERIMENTAL[Mindfulness training + sham tDCS]
PLACEBO COMPARATOR[Waiting list control group].
NO INTERVENTIONInterventions
The MT is an established app-based programme delivered by Headspace®. During MT, participants complete guided meditation sessions which focus on mindful eating and on coping with cravings. Each MT session lasts 15 min. Participants in the MT+ real tDCS and MT+ sham tDCS groups will be given instructions to practice daily mindfulness for 3 weeks. During 10 of these sessions, MT and real/sham tDCS will be delivered concurrently. TDCS: During tDCS, a constant weak direct current is applied via electrodes (anode and cathode) placed on the scalp. In this study, the anode will be placed over the right dorsolateral prefrontal cortex (dlPFC) and the cathode will be placed over the left dlPFC. In the real tDCS condition, stimulation will be delivered at a constant current of 2 mA with a 10 second fade in/fade out for 20 minutes. In sham tDCS, the stimulator will deliver 60 seconds of active stimulation at the start ("ramping up") and end ("ramping down") of the 20 minute period.
Mindfulness training + sham tDCS
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 60 w
- Overweight or obese (BMI ≥25 kg/ m2) according to World Health Organisation (WHO) criteria.
- Use and understand English as a language for everyday conversation.
- Have access to a laptop or desktop computer with webcam and to able to attend baseline, post intervention and follow up assessments in the Institute of Psychiatry, Psychology and Neuroscience (KCL).
You may not qualify if:
- Insufficient written and spoken English
- All known contraindications to tDCS (Brunoni et al., 2012)
- Pregnancy; history of neurological disease and/or seizure
- Having any metallic implants in the head or body
- History of head or eye injury
- Significant health problems in the previous six months
- A lifetime diagnosis of substance dependence, psychosis, bipolar disorder, borderline personality disorder; any other primary psychiatric disorder requiring treatment in its own right
- Taking psychotropic medication
- Taking medication for weight loss Regular, current or past, mindfulness meditation or yoga practice (defined as \> 20 minutes, twice or more per week during the past 2 months)
- Consuming more than 14 units of alcohol per week who are unwilling to reduce their alcohol intake for the duration of the treatment
- Current illicit drug use
- Learning difficulties that would preclude safe tDCS self-administration and/or completion of questionnaire measures and neurocognitive tasks (e.g.; working memory and inhibitory control)
- Current atypical anorexia nervosa or purging once a week or more.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CREW
London, Uk, SE5 8AF, United Kingdom
Related Publications (1)
Ageeli M, Flynn M, Lopes M, Ince B, Alves D, Westwood SJ, Campbell IC, Schmidt U. A feasibility study of the effects of concurrent transcranial direct current stimulation (tDCS) on mindfulness training in adults living with overweight or obesity: the MINDED trial protocol. Pilot Feasibility Stud. 2026 Jan 6. doi: 10.1186/s40814-025-01748-9. Online ahead of print.
PMID: 41495839DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2023
First Posted
May 19, 2023
Study Start
October 17, 2023
Primary Completion
February 19, 2025
Study Completion
February 19, 2025
Last Updated
July 28, 2025
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share